Skip to main content

Table 2 Power estimates for the full cohort analysis in which the treatment effect is diluted; d denotes the proportion of subjects with zero or multiple genetic variants in whom there is a difference between the predicted initial doses

From: Statistical design of personalized medicine interventions: The Clarification of Optimal Anticoagulation through Genetics (COAG) trial

d

Treatment Effect

Power

0.7

3.84

65%

0.8

4.39

77%

0.9

4.94

86%

1.0 (Undiluted)

5.49

93%